Stopped: Sponsor closed enrollment early based on interim data from the PRISM US Pivotal Study.
The purpose of this study is to evaluate the safety and effectiveness of an implantable device to treat migraine. There are a significant number of patients who have drug refractory migraine and alternative therapies are needed.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Hours of Headache
Timeframe: 12 weeks
Number of Days With 4 or More Hours of Headache
Timeframe: 12 Weeks